Skip to main content
Fig. 2 | BMC Complementary Medicine and Therapies

Fig. 2

From: Investigation of the activity of baicalein towards Zika virus

Fig. 2

Virus inactivation activity of baicalein. Stock ZIKV was directly incubated with baicalein at final concentrations of 100, 250, and 500 µM or with an equivalent percentage of vehicle control at 37 ºC for 1, 3, or 6 h before titer was determined by plaque assay. Experiments were performed independently in triplicate with duplicate plaque assay. Error bars show mean ± SD and p-value compared to the appropriate DMSO control (* p-value < 0.05, ** p-value < 0.01, *** p-value < 0.001)

Back to article page